These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 33037191)

  • 21. The AURKA/TPX2 axis drives colon tumorigenesis cooperatively with MYC.
    Takahashi Y; Sheridan P; Niida A; Sawada G; Uchi R; Mizuno H; Kurashige J; Sugimachi K; Sasaki S; Shimada Y; Hase K; Kusunoki M; Kudo S; Watanabe M; Yamada K; Sugihara K; Yamamoto H; Suzuki A; Doki Y; Miyano S; Mori M; Mimori K
    Ann Oncol; 2015 May; 26(5):935-942. PubMed ID: 25632068
    [TBL] [Abstract][Full Text] [Related]  

  • 22. RB1-deficient prostate tumor growth and metastasis are vulnerable to ferroptosis induction via the E2F/ACSL4 axis.
    Wang ME; Chen J; Lu Y; Bawcom AR; Wu J; Ou J; Asara JM; Armstrong AJ; Wang Q; Li L; Wang Y; Huang J; Chen M
    J Clin Invest; 2023 May; 133(10):. PubMed ID: 36928314
    [TBL] [Abstract][Full Text] [Related]  

  • 23.
    Marshall AE; Roes MV; Passos DT; DeWeerd MC; Chaikovsky AC; Sage J; Howlett CJ; Dick FA
    Mol Cell Biol; 2019 Aug; 39(16):. PubMed ID: 31138663
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of RB-deficient retinoblastoma with Aurora-A kinase inhibitor.
    Yang W; Jiang XX; Zhao XY; Mao PA
    Kaohsiung J Med Sci; 2022 Mar; 38(3):244-252. PubMed ID: 34741392
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An integrated genomic approach to identify predictive biomarkers of response to the aurora kinase inhibitor PF-03814735.
    Hook KE; Garza SJ; Lira ME; Ching KA; Lee NV; Cao J; Yuan J; Ye J; Ozeck M; Shi ST; Zheng X; Rejto PA; Kan JL; Christensen JG; Pavlicek A
    Mol Cancer Ther; 2012 Mar; 11(3):710-9. PubMed ID: 22222631
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Microtubule Network and Cell Death Are Regulated by an miR-34a/Stathmin 1/βIII-Tubulin Axis.
    Vetter NS; Kolb EA; Mills CC; Sampson VB
    Mol Cancer Res; 2017 Jul; 15(7):953-964. PubMed ID: 28275089
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CRISPR/Cas9 screening identifies a kinetochore-microtubule dependent mechanism for Aurora-A inhibitor resistance in breast cancer.
    Chen A; Wen S; Liu F; Zhang Z; Liu M; Wu Y; He B; Yan M; Kang T; Lam EW; Wang Z; Liu Q
    Cancer Commun (Lond); 2021 Feb; 41(2):121-139. PubMed ID: 33471959
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stathmin destabilizing microtubule dynamics promotes malignant potential in cancer cells by epithelial-mesenchymal transition.
    Lu Y; Liu C; Xu YF; Cheng H; Shi S; Wu CT; Yu XJ
    Hepatobiliary Pancreat Dis Int; 2014 Aug; 13(4):386-94. PubMed ID: 25100123
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cell Cycle and Beyond: Exploiting New RB1 Controlled Mechanisms for Cancer Therapy.
    Knudsen ES; Pruitt SC; Hershberger PA; Witkiewicz AK; Goodrich DW
    Trends Cancer; 2019 May; 5(5):308-324. PubMed ID: 31174843
    [TBL] [Abstract][Full Text] [Related]  

  • 30.
    Fang Z; Wang Y; Wang Z; Xu M; Ren S; Yang D; Hong M; Xie W
    Cancer Res; 2020 Oct; 80(20):4399-4413. PubMed ID: 32826278
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phosphorylation of pRb: mechanism for RB pathway inactivation in MYCN-amplified retinoblastoma.
    Ewens KG; Bhatti TR; Moran KA; Richards-Yutz J; Shields CL; Eagle RC; Ganguly A
    Cancer Med; 2017 Mar; 6(3):619-630. PubMed ID: 28211617
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aurora-A/ERK1/2/mTOR axis promotes tumor progression in triple-negative breast cancer and dual-targeting Aurora-A/mTOR shows synthetic lethality.
    Zhang W; Xia D; Li Z; Zhou T; Chen T; Wu Z; Zhou W; Li Z; Li L; Xu J
    Cell Death Dis; 2019 Aug; 10(8):606. PubMed ID: 31406104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of high level E2F in a RB1 proficient MYCN overexpressing chicken retinoblastoma model normalizes neoplastic behaviour.
    Zhang H; Konjusha D; Rafati N; Tararuk T; Hallböök F
    Cell Oncol (Dordr); 2024 Feb; 47(1):209-227. PubMed ID: 37606819
    [TBL] [Abstract][Full Text] [Related]  

  • 34. GLUT1 inhibition blocks growth of RB1-positive triple negative breast cancer.
    Wu Q; Ba-Alawi W; Deblois G; Cruickshank J; Duan S; Lima-Fernandes E; Haight J; Tonekaboni SAM; Fortier AM; Kuasne H; McKee TD; Mahmoud H; Kushida M; Cameron S; Dogan-Artun N; Chen W; Nie Y; Zhang LX; Vellanki RN; Zhou S; Prinos P; Wouters BG; Dirks PB; Done SJ; Park M; Cescon DW; Haibe-Kains B; Lupien M; Arrowsmith CH
    Nat Commun; 2020 Aug; 11(1):4205. PubMed ID: 32826891
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stathmin activity influences sarcoma cell shape, motility, and metastatic potential.
    Belletti B; Nicoloso MS; Schiappacassi M; Berton S; Lovat F; Wolf K; Canzonieri V; D'Andrea S; Zucchetto A; Friedl P; Colombatti A; Baldassarre G
    Mol Biol Cell; 2008 May; 19(5):2003-13. PubMed ID: 18305103
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retinoblastoma mutation predicts poor outcomes in advanced non small cell lung cancer.
    Bhateja P; Chiu M; Wildey G; Lipka MB; Fu P; Yang MCL; Ardeshir-Larijani F; Sharma N; Dowlati A
    Cancer Med; 2019 Apr; 8(4):1459-1466. PubMed ID: 30773851
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined Aurora Kinase A (AURKA) and WEE1 Inhibition Demonstrates Synergistic Antitumor Effect in Squamous Cell Carcinoma of the Head and Neck.
    Lee JW; Parameswaran J; Sandoval-Schaefer T; Eoh KJ; Yang DH; Zhu F; Mehra R; Sharma R; Gaffney SG; Perry EB; Townsend JP; Serebriiskii IG; Golemis EA; Issaeva N; Yarbrough WG; Koo JS; Burtness B
    Clin Cancer Res; 2019 Jun; 25(11):3430-3442. PubMed ID: 30755439
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutant RB1 enhances therapeutic efficacy of PARPis in lung adenocarcinoma by triggering the cGAS/STING pathway.
    Dong Q; Yu T; Chen B; Liu M; Sun X; Cao H; Liu K; Xu H; Wang Y; Zhuang S; Jin Z; Liang H; Hui Y; Gu Y
    JCI Insight; 2023 Nov; 8(21):. PubMed ID: 37937640
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modeling Developmental and Tumorigenic Aspects of Trilateral Retinoblastoma via Human Embryonic Stem Cells.
    Avior Y; Lezmi E; Yanuka D; Benvenisty N
    Stem Cell Reports; 2017 May; 8(5):1354-1365. PubMed ID: 28392220
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Silencing Aurora-A with siRNA inhibits cell proliferation in human lung adenocarcinoma cells.
    Zhong N; Shi S; Wang H; Wu G; Wang Y; Ma Q; Wang H; Liu Y; Wang J
    Int J Oncol; 2016 Sep; 49(3):1028-38. PubMed ID: 27571708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.